Recombinant FCRL5 (Cevostamab Biosimilar) antibody

Catalog No. ABIN7490924

This Humanized Monoclonal antibody specifically detects FCRL5 (Cevostamab Biosimilar) in FACS and ELISA. It exhibits reactivity toward Human.

Quick Overview for Recombinant FCRL5 (Cevostamab Biosimilar) antibody (ABIN7490924)

Target: FCRL5 (Cevostamab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This FCRL5 (Cevostamab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), ELISA

Grade: Research Grade

Product Details anti-FCRL5 (Cevostamab Biosimilar) Antibody

Purpose: Anti-FCRL5 (cevostamab biosimilar without anti-CD3 portion) mAb

Characteristics: BFCR-4350-A, BFCR-4350A, RG-6160, RO-7187797

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG1

Application Details

Application Notes: ELISA 1:5000-10000, Flow Cyt 1:100

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for FCRL5 (Cevostamab Biosimilar)

Target: FCRL5 (Cevostamab Biosimilar)

Target Type: Biosimilar

Background: Synonyms: BXMAS1, CD307, CD307e, FCRH5, IRTA2, PRO820

UniProt: Q96RD9